In FXS patient brain cortexes, full-length BMPR2 protein and phospho-cofilin levels are both increased (Kashima et al., 2016), consistent with the Drosophila and mouse FXS model discoveries. The gene discussed is CFL1; the disease is fragile X syndrome.